Dimebon, a drug that has been in phase three of clinical trials for treatment of Alzheimer’s disease, has recently been discontinued after studies concluded it was ineffective. Dimebon is a drug that was first used in Russia decades ago as an antihistamine, and in the last few years has undergone testing to treat the symptoms of Alzheimer’s in the United States. Dimebon was never sold or marketed in the United States.

Initially, the drug showed some positive results in patients with Alzheimer’s, so clinical trials were expanded to study its effects when given with the drug denepazil (Aricept), a medication currently used to treat early Alzheimer’s. This past week, Pfizer and Medivation, the two drug companies that were conducting the trials, announced the discontinuation of Dimebon after it failed to show benefits for the recipients. In fact, some of the people receiving it declined more than those who received the placebo.

This is disappointing news, especially in light of ournation’s recent draft document on Alzheimer’s disease and other related dementias. One goal outlined in this draft is to effectively treat and prevent Alzheimer’s by 2025. Evidently, the manner in which we do this won’t include Dimebon.

http://alzheimers.about.com/b/2012/01/22/potential-alzheimers-drug-dimebon-fails-in-clinical-trials.htm

automatic cat feeder

Puerto Morelos Gay Travel Discount Tour Packages – Chichen Itza Tulum Isles Mujures

Dimebon Dimebolin Information Availability

]]> http://dimebonalzheimers.com/1202/potential-alzheimers-dimebon-fails/feed/ 0 http://dimebonalzheimers.com/138/dimebon-dimebolin-information-availability-3/ http://dimebonalzheimers.com/138/dimebon-dimebolin-information-availability-3/#comments Sun, 15 Mar 2009 13:47:00 +0000 admin http://dimebonalzheimers.vintageomputermanuals.com/?p=138
Dimebom is a new pharmaceutical treatment alternative for patients suffering from Alzheimer’s Disease.   Dimebon is an older medication that has recently been discovered to be most helpful in treating patients with Alzheimer’s disease.   Dimebom (the actual drug is known chemically as Dimebolin) is an older  Russian antihistamine drug.  It was popularly used in Russia as [...]



]]>

Dimebom is a new pharmaceutical treatment alternative for patients suffering from Alzheimer’s Disease.   Dimebon is an older medication that has recently been discovered to be most helpful in treating patients with Alzheimer’s disease.   Dimebom (the actual drug is known chemically as Dimebolin) is an older  Russian antihistamine drug.  It was popularly used in Russia as an antihistamine for hayfever, allergies and the like.  In fact the drug was sold as an easy to obtain antihistamine – sold over the counter without a prescription.

Dimebom is currently in clinical trials in the United States by a company named Medivation .    The website for Medivation, the pharmaceutical company involved with the clinical development and testing of Dimebom in the United States? Can be found at link   www.medivation.com .   To learn more about Medivation’s clinical trials of Dimebom the link is

http://www.medivation.com/pipeline_dimebontrials.html#p3

For more information on CONNECTION study locations, eligibility and enrollment, please visit www.connectionstudy.com or call toll-free 1-877-888-6386

At this point in time Dimebom is not available in any manner to Alzheimer Patients or their families, outside of the study material afforded by the Medivation Company and the Medivation clinical trials themselves.

Dimebon Alzheimer?s Disease

http://www.dimebonalzheimers.com

Dimebom is a new pharmaceutical treatment alternative for patients suffering from Alzheimer’s Disease

Dimebon is an older medication that has recently been discovered to be most helpful in treating patients with Alzheimer’s Disease

Dimebon ( the actual drug is known chemically as Dimebolin) is an older Russian antihistamine drug.  It was popularly used in Russia as an antihistamine for hayfever , allergies and the like.  In fact the drug was sold as an easy to obtain antihistamine -  sold over the counter without a prescription.

Dimebon is currently in clinical trials in the United States by a company named  Medivation . The website for Medivation company can be found at http://www.medivation.com/

Dimebon and the clinical trial information of Medivation can be found at this link on the internet

http://www.medivation.com/pipeline_dimebontrials.html

At this point in time Dimebon is not available in any manner outside of the study material afforded by the Medivation company and the Medivation clinical trials themselves.

Dimebon Alzheimer’s Disease

http://www.dimebonalzheimers.com